One Ascent Financial Services LLC Myovant Sciences Ltd. Transaction History

One Ascent Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 21, 2020	SELL	$7.34 - $20.84 $123,400 - $350,362	-16,812 Closed	0 $0
Q1 2020 Apr 14, 2020	SELL	$6.55 - $14.76 $127,829 - $288,056	-19,516 Reduced 53.72%	16,812 $127,000
Q4 2019 Feb 11, 2020	BUY	$4.2 - $19.21 $152,577 - $697,860	36,328 New	36,328 $564,000
Q3 2019 Nov 15, 2019	SELL	$5.19 - $9.46 $98,355 - $179,276	-18,951 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$8.69 - $25.0 $164,684 - $473,775	18,951 New	18,951 $172,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Financial Services LLC with notifications on news.